At Children's Hospital, highly experienced teams work together to develop clinical pathways for treating various conditions.
FDA Approves Personalized Cellular Therapy for Advanced Leukemia Developed by University of Pennsylvania and Children's Hospital of Philadelphia
FDA's approval is a pivotal milestone in this new era of cellular therapies that treat leukemia with a patient's own immune system.
A new professional development opportunity allows nurses to visit international pediatric facilities and meet the clinical staff caring for patients.
A team of researchers at Children's Hospital has innovated a new womb-like device that may dramatically reduce the effects of prematurity.